Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HELBO is an Austrian medical technology company that pioneered the use of antimicrobial photodynamic therapy (aPDT) in dentistry. Its core offering, the HELBO therapy, utilizes a specific diode laser in combination with a light-sensitive dye known as a photosensitizer to eliminate pathogenic bacteria and fungi. This non-invasive approach is designed to treat inflammatory conditions like periodontitis and peri-implantitis effectively without the need for systemic antibiotics or surgical intervention. The company provides a comprehensive system including the HELBO TheraLite Laser and the HELBO Blue photosensitizer. Now a subsidiary of the Bredent Group, HELBO's solutions are widely integrated into professional dental workflows to promote tissue healing and long-term oral health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HELBO.